Abstract |
A series of monomeric and dimeric naphthoquinones with potential for treatment of Leishmania infections was identified in vitro using both a direct cytotoxicity assay against extracellular promastigotes of Leishmania donovani, L. infantum, L. enriettii, and L. major and a test against intracellular amastigote L. donovani residing within murine macrophages. Several naphthoquinones proved to be active at concentrations in the microgram range (EC(50) 0.9-17.0 microg/ml). When tested against a panel of human cancer cell lines (KB, SKMel, A549, MDA) and murine bone marrow culture-derived macrophages (BMMPhi) as mammalian host cell controls, compounds with anti-Leishmania-activity showed moderate (EC(50)>25 microg/ml) to pronounced (EC(50)<10 microg/ml) toxic effects.
|
Authors | O Kayser, A F Kiderlen, H Laatsch, S L Croft |
Journal | Acta tropica
(Acta Trop)
Vol. 77
Issue 3
Pg. 307-14
(Dec 01 2000)
ISSN: 0001-706X [Print] Netherlands |
PMID | 11114393
(Publication Type: Journal Article)
|
Chemical References |
- Antiprotozoal Agents
- Naphthoquinones
|
Topics |
- Animals
- Antiprotozoal Agents
(pharmacology)
- Humans
- Leishmania
(drug effects)
- Naphthoquinones
(pharmacology)
- Structure-Activity Relationship
|